- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Joe Antos on the Changing Dynamics of ACOs in the Future
While Joe Antos, PhD, the Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American Enterprise Institute, believes that the ACO model is here to stay, he said that the way these organizations operate are likely to change.
While Joe Antos, PhD, the Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American Enterprise Institute, believes that the ACO model is here to stay, he said that the way these organizations operate are likely to change.
Transcript (slightly modified)
Are ACOs here to stay or are they a stepping stone to another delivery model?
Well, my crystal ball is a little unclear at the moment as far as what the next thing is. But, the term ACO is going to be with us for some time but the way they operate, and the ACOs that are now in place, I think are going to continue for a considerable amount of time. But I think the rules under which they operate will change and I think that’s a good thing.
They themselves have proposed changes to make it more possible for them to reach out to clients, reach out to patients, do a better job of directing patients to, let me call them, in-network providers, and this whole idea of having an in-network plan makes sense. This is what we have for the under 65 population, virtually everyone who has insurance has the option of going in-network or out of network. That’s the idea. So this is an idea that’s here to stay, but the specifics are going to change. I hope for the better.
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More
